ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT)

15.19USD -6.06% (-0.98)

Over 6M: +81.9%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

5 10 15
Mar Apr May Jun Jul Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Income: -53.8M Q3 '21 — Free Cash Flow: -18.4M Q4 '21 — Operating Income: -37.6M Q4 '21 — Free Cash Flow: -43.6M Q1 '22 — Operating Income: -50.4M Q1 '22 — Free Cash Flow: -51.1M Q2 '22 — Operating Income: -22.1M Q2 '22 — Free Cash Flow: -37.2M Q3 '22 — Operating Income: -36.8M Q3 '22 — Free Cash Flow: -44.6M Q4 '22 — Operating Income: 121.5M Q4 '22 — Free Cash Flow: 156.5M Q1 '23 — Operating Income: 14.8M Q1 '23 — Free Cash Flow: -36.6M Q2 '23 — Operating Income: -55.4M Q2 '23 — Free Cash Flow: 50.5M Q3 '23 — Operating Income: -19.3M Q3 '23 — Free Cash Flow: -33.4M Q4 '23 — Operating Income: -18.3M Q4 '23 — Free Cash Flow: -1.5M Q1 '24 — Operating Income: -30.4M Q1 '24 — Free Cash Flow: -5.8M Q2 '24 — Operating Income: -21.1M Q2 '24 — Free Cash Flow: -30.5M Q3 '24 — Operating Income: -10.7M Q3 '24 — Free Cash Flow: -23.8M Q4 '24 — Operating Income: -33.4M Q4 '24 — Free Cash Flow: -284K Q1 '25 — Operating Income: -16.8M Q1 '25 — Free Cash Flow: -35.3M Q2 '25 — Operating Income: -11.6M Q2 '25 — Free Cash Flow: -5.8M Q3 '25 — Operating Income: -16.5M Q3 '25 — Free Cash Flow: -17.3M Q4 '25 — Operating Income: -31.3M Q4 '25 — Free Cash Flow: -16.3M Q1 '26 — Operating Income: -28.9M Q1 '26 — Free Cash Flow: -19.4M Q2 '26 — Operating Income: -25.5M Q2 '26 — Free Cash Flow: -19.9M -50M 0 50M 100M 150M 200M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Operating Income Free Cash Flow

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 62 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 71.9%
OE margin -319.8%
Oper. margin -348.3%
Accruals -9.2%
EBITDA margin -339.0%
FCF margin -248.0%
OCF margin -247.7%
Profit margin -317.6%
ROA -41.6%
ROCE -53.6%
ROE -54.3%
Gross margin —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

3.6
EV/Sales 8.2×
EV/OE -2.6×
P/C 2.3×
P/B 2.5×
FCF yield -16.9%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.9
RPO / sales 0.21×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.7
ND/EBITDA 0.8
Cash runway 2.6 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 5.9×
F-score 1.3 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

3.1
Sales CAGR 4Y +60.5%
Sales/sh Y/Y -76.3%
Sales Q/Q -89.5%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.